Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Dulaglutide (Trulicity) A weekly injection approved in 2014, at 0.75 mg to 4.5 mg, with cardiovascular-outcomes data
Blog Posts Genitourinary Syndrome of Menopause (GSM) Learn about Genitourinary Syndrome of Menopause (GSM), including vaginal dryness, painful intercourse, recurrent UTIs, urinary symptoms, and evidence-based hormonal and non-hormonal treatments to improve comfort, intimacy, and quality of life
Ding, B
For localized musculoskeletal injuries, perilesional intramuscular or intratendinous injections may provide enhanced local effects, though systemic administration alone often suffices
doi:10.1186/1550-2783-10-36
US$ 22.64
US$ 27.91
US$ 22.70
